Editorial Board — Medscape Gastroenterology

Chair/Journal Editor

 

Board Members

  • Paul Martin, MD
    • University of Miami School of Medicine and Hospital
      Miami, Florida
  • Valerio Nobili, MD
    • Bambino Gesù Children's Hospital
      Rome, Italy
  • Brant K. Oelschlager, MD
    • University of Washington
      University of Washington Medical Center
      Seattle, Washington
  • Nancy S. Reau, MD
    • Department of Internal Medicine
      Rush University
      Rush University Medical Center
      Chicago, Illinois
  • Douglas K. Rex, MD
    • Indiana University
      Indiana University Hospital
      Indianapolis, Indiana
 

Chair/Journal Editor Details

Geoffrey Braden, MD
Geoffrey Braden, MD

Chairman, Department of Medicine, Aria Jefferson Health System, Philadelphia, Pennsylvania

Geoffrey Braden, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Janssen Biotech; AbbVie
Serve(d) as a speaker or member of a speakers bureau for: Janssen Biotech; AbbVie
Received income in an amount equal to or greater than $250 from: Janssen Biotech; AbbVie; Allergan

 

Board Member Details

David L. Carr-Locke, MD
David L. Carr-Locke, MD

Professor of Medicine, Icahn School of Medicine at Mount Sinai; Chief, Division of Digestive Diseases, Mount Sinai Beth Israel Medical Center, New York, New York

David L. Carr-Locke, MD, has disclosed the following relevant financial relationships:
Serve(d) as a sidrector, officer, partner, employee, advisor, consultant, or trustee for: Boston Scientific Edoscopy; Cook Medical; EndoChoice
Received income in an amount equal to or greater than $250 from: US Endoscopy; Telemed Systems

Stephen Hanauer, MD
Stephen Hanauer, MD

Professor of Medicine, Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Stephen B. Hanauer, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie; Actavis Group hf; Allergan, Inc; Amgen Inc; Arena Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene; Celltrion; Ferring Pharmaceuticals; Genentech BioOncology; GlaxoSmithKline; Hospira, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Eli Lilly and Company; Merck & Co; Nestle; Novartis Pharmaceuticals Corporation; Pfizer, Inc; Prometheus Laboratories Inc.; Receptos; Salix Pharmaceuticals, Inc.; Samsung Bioepis; Seres Health; Shire; Takeda Pharmaceuticals North America, Inc.; TiGenix; UCB Pharma, Inc.; VHsquared

David A. Johnson, MD
David A. Johnson, MD

Professor of Medicine, Chief of Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia

David A. Johnson, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer Inc; CRH Medical; American Board of Internal Medicine
Received income in an amount equal to or greater than $250 from: Pfizer Inc; CRH Medical; American Board of Internal Medicine

Philip O. Katz, MD
Philip O. Katz, MD

Clinical Professor of Medicine, The Sidney Kimmel Medical College at Thomas Jefferson University; Chairman, Division of Gastroenterology, Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania

Phillip O. Katz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer Inc.; Torax Medical

Brian E. Lacy, MD, PhD
Brian E. Lacy, MD, PhD

Professor and Section Chief, Gastroenterology and Hepatology, Department of Medicine; Director, GI Motility Laboratory, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Brian E. Lacy, MD, PhD, has disclosed the following relevant financial relationships:
Member of scientific advisory boards for: Ironwood Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.
Received a research grant from: National Institutes of Health
Scientific Advisory Board, yearly meetings: Salix Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Ironwood Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.

Bret A. Lashner, MD
Bret A. Lashner, MD

Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Bret A. Lashner, MD, has disclosed no relevant financial relationships.

Paul Martin, MD
Paul Martin, MD

Professor of Medicine, University of Miami School of Medicine; Chief, Division of Gastroenterology and Hepatology, University of Miami Hospital, Miami, Florida

Paul Martin, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Bristol-Myers Squibb Company; AbbVie
Received income in an amount equal to or greater than $250 from: Gilead Sciences, Inc; Merck & Co.; Bristol-Myers Squibb Company; AbbVie

Valerio Nobili, MD
Valerio Nobili, MD

Associate Professor, University of Rome La Sapienza; Director, Hepatometabolic Unit, Bambino Gesù Children’s Hospital, Rome, Italy

Valerio Nobili, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Alexion; Bristol-Myers Squibb Company

Brant Oelschlager, MD
Brant Oelschlager, MD

Professor, Vice Chair, and Chief, Division of General Surgery, Department of Surgery, University of Washington; Director, Center for Esophageal and Gastric Surgery, University of Washington Medical Center, Seattle, Washington

Brant Oelschlanger, MD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: EndoStim (Data Safety Committee for trial)

Douglas K. Rex, MD
Douglas Rex, MD

Douglas K. Rex, MD, Distinguished Professor of Medicine, Indiana University; Director of Endoscopy, Indiana University Hospital, Indianapolis, Indiana

Douglas K. Rex, MD, has disclosed the following relevant financial relationships:
Served(d) as a consultant for: Boston Scientific; Olympus
Received research support from: Boston Scientific; Colonary Solutions; Covidien; Medtronic, Inc.; EndoAid, Ltd; Endochoice; Olympus; Paion AG

Nancy S. Reau, MD
Nancy S. Reau, MD

Professor, Department of Internal Medicine, Rush University; Section Chief, Hepatology; Associate Director of Organ Transplant, Rush University Medical Center, Chicago, Illinois

Nancy Reau, MD, has disclosed the following financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie Inc.; Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Intercept Pharmaceuticals, Inc.
Received income in an amount equal to or greater than $250 from: American Board of Internal Medicine